Virodhamine

WikiDoc Resources for Virodhamine
Articles
Most recent articles on Virodhamine Most cited articles on Virodhamine Review articles on Virodhamine Articles on Virodhamine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Virodhamine Images of Virodhamine Photos of Virodhamine Podcasts & MP3s on Virodhamine Videos on Virodhamine
Evidence Based Medicine
Cochrane Collaboration on Virodhamine Bandolier on Virodhamine TRIP on Virodhamine
Clinical Trials
Ongoing Trials on Virodhamine at Clinical Trials.gov Trial results on Virodhamine Clinical Trials on Virodhamine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Virodhamine NICE Guidance on Virodhamine NHS PRODIGY Guidance FDA on Virodhamine CDC on Virodhamine
Books
Books on Virodhamine
News
Virodhamine in the news Be alerted to news on Virodhamine News trends on Virodhamine
Commentary
Blogs on Virodhamine
Definitions
Definitions of Virodhamine
Patient Resources / Community
Patient resources on Virodhamine Discussion groups on Virodhamine Patient Handouts on Virodhamine Directions to Hospitals Treating Virodhamine Risk calculators and risk factors for Virodhamine
Healthcare Provider Resources
Symptoms of Virodhamine Causes & Risk Factors for Virodhamine Diagnostic studies for Virodhamine Treatment of Virodhamine
Continuing Medical Education (CME)
CME Programs on Virodhamine
International
Virodhamine en Espanol Virodhamine en Francais
Business
Virodhamine in the Marketplace Patents on Virodhamine
Experimental / Informatics
List of terms related to Virodhamine

Virodhamine (O-arachidonoyl ethanolamine) is an endocannibinoid and a nonclassic eicosanoid, derived from arachidonic acid. O-Arachidonoyl ethanolamine is arachidonic acid and ethanolamine joined by an ester linkage, the opposite of the amide linkage found in anandamide. Based on this opposite orientation, the molecule was named virodhamine from the Sanskrit word virodha, which means opposition. It is an antagonist of the CB1 receptor and an agonist of CB2. Concentrations of virodhamine in the human hippocampus are similar to anandamide, but they were 2- to 9-fold higher in peripheral tissues that express CB2. Virodhamine lowers body temperature in mice, demonstrating cannabinoid activity in vivo.